Rifaximin, a poorly absorbed antibiotic; pharmacology and clinical use.3805579179Rifaximin, a poorly absorbed antibiotic; pharmacology and clinical use. Ed. by C. Scarpignato. S. Karger, AG 2005 238 pages $89.25 Hardcover RM666 Rifaximin, a semisynthetic semisynthetic /semi·syn·thet·ic/ (-sin-thet´ik) produced by chemical manipulation of naturally occurring substances. sem·i·syn·thet·ic adj. 1. rifamycin rifamycin /rif·a·my·cin/ (rif?ah-mi´sin) any of a family of antibiotics biosynthesized by a strain of Streptomyces mediterranei, which is nonabsorbable in the gastrointestinal tract gastrointestinal tract n. The part of the digestive system consisting of the stomach, small intestine, and large intestine. Gastrointestinal tract , has been available in Europe and other countries for several years and has recently been approved in the US for treatment of traveler's diarrhea Traveler's Diarrhea Definition The occurrence of multiple loose bowel movements in someone traveling to an area outside their usual surroundings (usually from temperate industrialized regions to tropical areas), is known as Traveler's diarrhea (TD). . This volume brings together all of the available microbiology, pharmacology and clinical aspects of the drug in 12 commissioned monographic reviews by 30 internationally renowned scientists. The topics addressed include the pathogenesis of gastrointestinal bacterial overgrowth; the role of rifaximin in the management of hepatic encephalopathy; and management of diverticular disease. ([c] 2005 Book News, Inc., Portland, OR) |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion